Belén Navarro

[Blood Journals Portfolio @BloodPortfolio]

Longer time from last alkylating agent exposure was significantly associated with lower odds of manufacturing failure in patients with MM. Read the study in Blood ICT: https://t.co/PJ0YyQZVRi

[Raul Cordoba, MD, PhD @DrRaulCordoba]

Four decades of #clinicaltrials: 14.2 million life-years gained, at $326 per year
by ⁦@SWOG⁩ Cancer Research Network #hematology #oncology #research #innovation https://t.co/9WPu0phK5K

[Dr. Ramón García Sanz @RamonGarciaSanz]

FIRST NUMBER OF THE NEW "SANGRE"

[Belén Navarro @Bematilla]

#StopOPEmedicosFEA #FijezaMedicosFEA @madrid_ope2021 @mudmedicos

[Blood Journals Portfolio @BloodPortfolio]

Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage https://t.co/JtlbUU8IG8

[Blood Journals Portfolio @BloodPortfolio]

Systemic mastocytosis with an associated t(8;21)(q22;q22) acute myeloid leukemia https://t.co/qKAffWwJ0T